Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PHIO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | David H. Deming Director | PHIO Phio Pharmaceuticals Corp. | Buy | 5,200 | $0.838 | $4,358 Buy | Form 4 ↗ |
| Nov 10, 2026 | David H. Deming Director | PHIO Phio Pharmaceuticals Corp. | Buy | 6,800 | $0.8395 | $5,709 Buy | Form 4 ↗ |
| Nov 9, 2026 | Ronald Todd Plott Director | PHIO Phio Pharmaceuticals Corp. | Buy | 18,300 | $0.83 | $15.2K Buy | Form 4 ↗ |
| Nov 9, 2026 | Robert J. Bitterman Chairman, Pres. & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 25,000 | $0.82 | $20.5K Buy | Form 4 ↗ |
| Sep 29, 2026 | Ronald Todd Plott Director | PHIO Phio Pharmaceuticals Corp. | Buy | 5,000 | $1.04 | $5,200 Buy | Form 4 ↗ |
| Sep 28, 2026 | Ronald Todd Plott Director | PHIO Phio Pharmaceuticals Corp. | Buy | 5,000 | $1.03 | $5,150 Buy | Form 4 ↗ |
| Sep 24, 2026 | Patricia A. Bradford Director | PHIO Phio Pharmaceuticals Corp. | Buy | 6,500 | $1.01 | $6,565 Buy | Form 4 ↗ |
| Sep 22, 2026 | Robert J. Bitterman Chairman, Pres. & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 2,000 | $1.03 | $2,060 Buy | Form 4 ↗ |
| Sep 15, 2026 | Patricia A. Bradford Director | PHIO Phio Pharmaceuticals Corp. | Buy | 12,000 | $1.03 | $12.4K Buy | Form 4 ↗ |
| Aug 19, 2026 | Ronald Todd Plott Director | PHIO Phio Pharmaceuticals Corp. | Buy | 15,000 | $1.14 | $17.1K Buy | Form 4 ↗ |
| Aug 18, 2026 | Robert J. Bitterman Chairman, Pres. & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 10,000 | $1.06 | $10.6K Buy | Form 4 ↗ |
| Jun 26, 2026 | Robert J. Bitterman Chairman, Pres. & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 10,000 | $0.99 | $9,900 Buy | Form 4 ↗ |
| Dec 31, 2025 | Robert J. Bitterman Chairman, Pres. & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 5,000 | $1.03 | $5,150 Buy | Form 4 ↗ |
| Dec 23, 2025 | Robert J. Bitterman Chairman, Pres. & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 5,000 | $1.02 | $5,100 Buy | Form 4 ↗ |
| Nov 21, 2025 | Robert J. Bitterman Chairman, Pres. & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 5,000 | $1.14 | $5,700 Buy | Form 4 ↗ |
| Nov 18, 2025 | Robert J. Bitterman Chairman, Pres. & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 5,000 | $1.27 | $6,350 Buy | Form 4 ↗ |
| Jun 10, 2025 | Robert J. Bitterman Chairman, Pres & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 2,000 | $2.42 | $4,840 Buy | Form 4 ↗ |
| Jun 10, 2025 | Robert L. Ferrara Director | PHIO Phio Pharmaceuticals Corp. | Buy | 2,500 | $2.42 | $6,050 Buy | Form 4 ↗ |
| Jun 9, 2025 | Robert J. Bitterman Chairman, Pres & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 1,500 | $2.75 | $4,125 Buy | Form 4 ↗ |
| May 22, 2025 | Robert J. Bitterman Chairman, Pres & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 1,200 | $1.78 | $2,136 Buy | Form 4 ↗ |
| May 21, 2025 | Robert J. Bitterman Chairman, Pres & CEO, Director | PHIO Phio Pharmaceuticals Corp. | Buy | 3,000 | $1.77 | $5,310 Buy | Form 4 ↗ |
| May 20, 2025 | Robert L. Ferrara Director | PHIO Phio Pharmaceuticals Corp. | Buy | 2,500 | $1.82 | $4,550 Buy | Form 4 ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:40 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances